Contrast Induced Nephropathy: Clinical Trials

43 trials for Contrast Induced Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 10 unknown, 3 terminated, 3 withdrawn. 12 Phase 4, 10 Not applicable, 9 Phase 3, 6 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 7, Unknown 2, Withdrawn 2, Terminated 1
Not applicable10Completed 7, Recruiting 1, Terminated 1, Withdrawn 1
Phase 39Completed 4, Unknown 4, Recruiting 1
Phase 26Completed 4, Recruiting 1, Unknown 1
Early Phase 11Unknown 1
Phase 11Terminated 1

Follow Contrast Induced Nephropathy: new trials by email Literature Review of Contrast Induced Nephropathy trials Research Report on Contrast Induced Nephropathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation
Beetroot juice - Non ST Segment Elevation Acute Coronary Syndrome, Contrast Induced Nephropathy
Not applicableRecruitingHospital General Universitario Santa Lucia1302024-10-072025-05-18
Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
Pentoxifylline, Normal saline - Pentoxifylline, Contrast Induced Nephropathy
Not applicableCompletedTanta University702024-07-012026-05-01
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Remote ischemic preconditioning, Sham remote ischemic conditioning - Acute Kidney Injury, Heart Failure
Phase 2 / Phase 3RecruitingVA Office of Research and Development2402021-11-012025-12-15
Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
sodium bicarbonate, hypotone saline - Aortic Valve Disease, Chronic Kidney Disease
Phase 4UnknownSt. Antonius Hospital2002016-10-012017-04-19
Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study
Low Dose Contrast (Omnipaque) 40mL, Low Dose Contrast (Omnipaque) 50 mL - Aortic Aneurysm, Contrast Induced Nephropathy
Not applicableCompletedMilton S. Hershey Medical Center342016-02-012019-06-11
Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy
RIPC - Remote Ischaemic Preconditioning, Contrast Induced Nephropathy
Not applicableCompletedChangi General Hospital402015-01-012020-01-27
A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?
No prophylactic iv hydration - Contrast Induced Nephropathy, Acute Kidney Injury
Not applicableCompletedMaastricht University Medical Center6602014-04-012017-10-06
Metabolic Syndrome and Contrast Induced Nephropathy
Contrast Induced Nephropathy, Metabolic Syndrome
CompletedAnkara University5992014-02-012014-07-16
Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
contrast - Contrast Induced Nephropathy
CompletedSun Yat-sen University5922013-10-012016-01-08
Contrast Nephropathy and Nitrates
Intravenous Nitroglycerin, IV Fluids - Contrast Induced Nephropathy
Phase 4CompletedMt. Sinai Medical Center, Miami1222013-06-012019-10-29
REduction of rIsk for Contrast Induced Nephropathy
Contrast Induced Nephropathy
UnknownGuangdong Provincial People's Hospital50002013-01-012018-08-03
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
pentoxyphylline, placebo, pentoxiphylline - Contrast Induced Nephropathy, Diabetes Mellitus
Not applicableWithdrawnMeir Medical Center2012-12-012015-04-08
Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?
Remote ischaemic preconditioning - Contrast Induced Nephropathy, Remote Ischaemic Preconditioning
Not applicableCompletedMid Western Regional Hospital, Ireland1002012-11-012013-09-13
Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
Atorvastatin - Contrast Induced Nephropathy
Phase 3UnknownIsfahan University of Medical Sciences2012-01-012014-04-14
Evaluation of RenalGuardĀ® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
RenalGuard Therapy, Standard Therapy - Contrast Induced Nephropathy
Phase 3UnknownCardioRenal Systems, Inc.3262012-01-012023-02-16
PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio
Contrast Induced Nephropathy
CompletedGuangdong Provincial People's Hospital30002010-12-012014-09-16
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
Hydration, Acetylcysteine, Sodium bicarbonate - Contrast Induced Nephropathy
Not applicableCompletedOdense University Hospital7202010-04-012013-03-22
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
alpha tocopherol, placebo - Contrast Induced Nephropathy
Phase 3UnknownThammasat University2002010-01-012010-02-03
Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention
Contrast Induced Nephropathy
UnknownGuangdong Provincial People's Hospital20002010-01-012011-08-03
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
N-acetylcysteine and ascorbic acid - Contrast Induced Nephropathy
Early Phase 1UnknownUniversity of Thessaly1002009-01-012009-11-23

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Renal Insufficiency, Chronic (6)  ·  Acute Kidney Injury (5)  ·  Diabetes Mellitus (4)  ·  Kidney Diseases (4)  ·  Renal Insufficiency (2)  ·  Acute Coronary Syndrome (1)  ·  Angina, Stable (1)  ·  Aortic Aneurysm (1)  ·  Aortic Valve Disease (1)  ·  Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Critical Illness (1)  ·  Heart Failure (1)  ·  Metabolic Syndrome (1)

Broader conditions

Female Urogenital Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (14)  ·  Male Urogenital Diseases (14)  ·  Urogenital Diseases (14)  ·  Urologic Diseases (14)  ·  Kidney Diseases (10)  ·  Renal Insufficiency (10)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Disease Attributes (7)  ·  Pathologic Processes (7)  ·  Chronic Disease (6)  ·  Cardiovascular Diseases (5)  ·  Glucose Metabolism Disorders (5)  ·  Metabolic Diseases (5)  ·  Nutritional and Metabolic Diseases (5)

Interventions

Sodium Bicarbonate (11)  ·  Acetylcysteine (6)  ·  Sodium Chloride (3)  ·  Atorvastatin (2)  ·  Contrast Media (2)  ·  Glucose (2)  ·  Pentoxifylline (2)  ·  Saline Solution (2)  ·  Acetazolamide (1)  ·  Ascorbic Acid (1)  ·  Epoetin Alfa (1)  ·  Fluid Therapy (1)  ·  Furosemide (1)  ·  Gels (1)  ·  Iohexol (1)

Sponsors

Guangdong Provincial People's Hospital (3)  ·  Ospedale Misericordia e Dolce (2)  ·  Tehran University of Medical Sciences (2)  ·  Ankara University (1)  ·  Azienda USL Reggio Emilia - IRCCS (1)  ·  Bracco Diagnostics, Inc (1)  ·  Brigham and Women's Hospital (1)  ·  CardioRenal Systems, Inc. (1)  ·  CardioVascular Research Foundation, Korea (1)  ·  Centro Cardiologico Monzino (1)  ·  Changi General Hospital (1)  ·  Hospital General Universitario Santa Lucia (1)  ·  Isfahan University of Medical Sciences (1)  ·  Kaiser Permanente (1)  ·  King Faisal Specialist Hospital & Research Center (1)

Countries

United States (11)  ·  China (4)  ·  Iran (4)  ·  Italy (4)  ·  Canada (2)  ·  Netherlands (2)  ·  Singapore (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)  ·  Ireland (1)  ·  Mexico (1)  ·  Saudi Arabia (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Ahmad Iaminisharif, M.D. (2)  ·  Akbar Fotuhi, M.D. (2)  ·  Alireza Amirzadegan, M.D. (2)  ·  Amir Hossein Razavi, M.D. (2)  ·  Ebrahim Kassaian, M.D. (2)  ·  Gelareh Sadigh, M.D. (2)  ·  Gholamreza Davoodi, M.D. (2)  ·  Mauro Maioli, MD (2)  ·  Mohammad Reza Khatami, M.D. (2)  ·  Mojtaba Salarifar, M.D. (2)  ·  Saeid Sadeghian, M.D. (2)  ·  Sirus Darabian, M.D. (2)  ·  Yong Liu, MD (2)  ·  Abbas Soleimani, M.D. (1)  ·  Adis Tasanarong, MD (1)

Results publications

PMID 15150204, PMID 15519007, PMID 16391986, PMID 16807414, PMID 16949378, PMID 18295688, PMID 18768415, PMID 19829124, PMID 19845233, PMID 22230154, PMID 24500238, PMID 24714489, PMID 25800136, PMID 26026638, PMID 26301645, PMID 27881568, PMID 28233565, PMID 28254177, PMID 28487034, PMID 28866117, PMID 29089038, PMID 29328007, PMID 29424480, PMID 29519811, PMID 30487984, PMID 31047001, PMID 31179103, PMID 31193613, PMID 31217993, PMID 32285318, PMID 32867690, PMID 35361478, PMID 35574956, PMID 35942508, PMID 36645250, PMID 37137588, PMID 37503157, PMID 38860394, PMID 38942114, PMID 39301879, PMID 39878152

NIH funding

I01CX002045 (1)